High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients
Authors:
- Yasuhide MiyoshiYMYasuhide Miyoshi
- Hiroji UemuraHUHiroji Uemura
- Susumu UmemotoSUSusumu Umemoto
- Kentaro SakamakiKSKentaro Sakamaki
- Satoshi MoritaSMSatoshi Morita
- Kazuhiro SuzukiKSKazuhiro Suzuki
- Yasuhiro ShibataYSYasuhiro Shibata
- Naoya MasumoriNMNaoya Masumori
- Tomohiko IchikawaTITomohiko Ichikawa
- Atsushi MizokamiAMAtsushi Mizokami
- Yoshiki SugimuraYSYoshiki Sugimura
- Norio NonomuraNNNorio Nonomura
Open Access
- 26 September 2014
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 717
Abstract
There is currently no consensus on the correlations between androgen concentrations in prostate tissue and blood and stage and pathological grade of prostate cancer. In this study, we used a newly-developed ultra-sensitive liquid-chromatography tandem mass spectrometry method to measure testosterone (T) and dihydrotestosterone (DHT) concentrations in blood and needle biopsy prostate specimens from patients with prostate cancer. We analyzed androgen levels in 196 men diagnosed with prostate cancer. All patients had undergone systematic needle biopsy, and an additional needle biopsy from the peripheral zone was conducted for the simultaneous determination of T and DHT. We analyzed the relationships between T and DHT levels in tissue and blood and Gleason score, clinical stage, and percentage of positive biopsy cores, using multivariate analysis. The median T and DHT levels in blood were 3551.0 pg/mL and 330.5 pg/mL, respectively. There was a strong correlation between serum T and DHT. The median T and DHT levels in prostate tissue were 0.5667 pg/mg and 7.0625 pg/mg, respectively. In multivariate analysis, serum prostate-specific antigen and tissue T levels were significantly associated with poor prognosis; high T levels in prostate tissue were significantly related to high Gleason score (p = 0.041), advanced clinical stage (p = 0.002), and a high percentage of positive biopsy cores (p = 0.001). The results of this study indicate that high T levels in prostate tissue are related to high Gleason score, advanced clinical stage, and a high percentage of positive biopsy cores in patients with prostate cancer. T level in needle biopsy specimens may therefore be a useful prognostic factor in prostate cancer patients.Keywords
This publication has 20 references indexed in Scilit:
- Impact of pre‐treatment prostate tissue androgen content on the prediction of castration‐resistant prostate cancer development in patients treated with primary androgen deprivation therapyAndrology, 2013
- Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatmentBJU International, 2012
- Development of highly sensitive quantification method for testosterone and dihydrotestosterone in human serum and prostate tissue by liquid chromatography–electrospray ionization tandem mass spectrometrySteroids, 2009
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor GrowthCancer Research, 2008
- Testosterone and Prostate Cancer: An Historical Perspective on a Modern MythEuropean Urology, 2006
- Association Between the Dihydrotestosterone Level in the Prostate and Prostate Cancer Aggressiveness Using the Gleason ScoreJournal of Urology, 2006
- Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate CancerClinical Cancer Research, 2005
- Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistryThe Journal of Pathology, 1990
- Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: Unique importance of extratesticular androgens in menThe Journal of Steroid Biochemistry and Molecular Biology, 1989
- RELATIONSHIPS BETWEEN OESTRADIOL-17β, TESTOSTERONE, DIHYDROTESTOSTERONE AND 5α-ANDROSTANE-3α,17β-DIOL IN HUMAN BENIGN HYPERTROPHY AND CARCINOMA OF THE PROSTATEJournal of Endocrinology, 1981